TNF-alpha is Critical for Antitumor but Not Antiviral T Cell Immunity in Mice

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2007 Nov 10

PMID 17992258

Citations 124

Authors

Thomas Calzascia

Marc Pellegrini

Hakan Hall

Laurent Sabbagh

Nobuyuki Ono

Alisha R Elford

Tak W Mak

Pamela S Ohashi

Affiliations

Soon will be listed here.

Abstract

TNF-alpha antagonists are widely used in the treatment of inflammatory and autoimmune diseases, but their use is associated with reactivation of latent infections. This highlights the importance of TNF-alpha in immunity to certain pathogens and raises concerns that critical aspects of immune function are impaired in its absence. Unfortunately, the role of TNF-alpha in the regulation of T cell responses is clouded by a myriad of contradictory reports. Here, we show a role for TNF-alpha and its receptors, TNFR1 and TNFR2, specifically in antitumor immunity. TNF-alpha-deficient mice exhibited normal antiviral responses associated with strong inflammation. However, TNF-alpha/TNFR1-mediated signals on APCs and TNF-alpha/TNFR2 signals on T cells were critically required for effective priming, proliferation, and recruitment of tumor-specific T cells. Furthermore, in the absence of TNF-alpha signaling, tumor immune surveillance was severely abrogated. Finally, treatment with a CD40 agonist alone or in combination with TLR2 stimuli was able to rescue proliferation of TNF-alpha-deficient T cells. Therefore, TNF-alpha signaling may be required only for immune responses in conditions of limited immunostimulatory capacity, such as tumor surveillance. Importantly, these results suggest that prolonged continuous TNF-alpha blockade in patients may have long-term complications, including potential tumor development or progression.

Citing Articles

Discovery of novel TACE inhibitors using graph convolutional network, molecular docking, molecular dynamics simulation, and Biological evaluation.

Yasir M, Park J, Han E, Han J, Park W, Hassan M PLoS One. 2024; 19(12):e0315245.

PMID: 39729480 PMC: 11676921. DOI: 10.1371/journal.pone.0315245.

Acute remote ischemic conditioning enhances (CD3+)- but not (FoxP3+)-T-cell invasion in the tumor center and increases IL 17 and TNF-alpha expression in a murine melanoma model.

Rachunek-Medved K, Krauss S, Daigeler A, Adams C, Eckert F, Ganser K Front Immunol. 2024; 15:1501885.

PMID: 39650654 PMC: 11621216. DOI: 10.3389/fimmu.2024.1501885.

Identification of costimulatory molecule signatures for evaluating prognostic risk in non-small cell lung cancer.

Yang Y, Lu S, Gu G Heliyon. 2024; 10(17):e36816.

PMID: 39286099 PMC: 11403524. DOI: 10.1016/j.heliyon.2024.e36816.

Targeting TNFR2 for cancer immunotherapy: recent advances and future directions.

Li L, Ye R, Li Y, Pan H, Han S, Lu Y J Transl Med. 2024; 22(1):812.

PMID: 39223671 PMC: 11367783. DOI: 10.1186/s12967-024-05620-x.

Impaired Proliferation of CD8 T Cells Stimulated with Monocyte-Derived Dendritic Cells Previously Matured with Thapsigargin-Stimulated LAD2 Human Mast Cells.

Kalkusova K, Taborska P, Stakheev D, Rataj M, Smite S, Darras E J Immunol Res. 2024; 2024:5537948.

PMID: 39056014 PMC: 11272405. DOI: 10.1155/2024/5537948.

References

Li Q, Withoff S, Verma I . Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol. 2005; 26(6):318-25. DOI: 10.1016/j.it.2005.04.003. View

Rothe J, LESSLAUER W, Lotscher H, Lang Y, Koebel P, Kontgen F . Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 1993; 364(6440):798-802. DOI: 10.1038/364798a0. View

Moore R, Owens D, Stamp G, Arnott C, Burke F, East N . Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med. 1999; 5(7):828-31. DOI: 10.1038/10552. View

Wu A, Hua H, Munson S, McDevitt H . Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc Natl Acad Sci U S A. 2002; 99(19):12287-92. PMC: 129437. DOI: 10.1073/pnas.172382999. View

Marino M, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E . Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A. 1997; 94(15):8093-8. PMC: 21562. DOI: 10.1073/pnas.94.15.8093. View

Meager A . Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev. 1999; 10(1):27-39. DOI: 10.1016/s1359-6101(98)00024-0. View

Mackay F, Loetscher H, Stueber D, Gehr G, LESSLAUER W . Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med. 1993; 177(5):1277-86. PMC: 2190994. DOI: 10.1084/jem.177.5.1277. View

Kawai K, Kundig T, Odermatt B, Bachmann M, Zakarian A, Mak T . Absence of TNFRp55 influences virus-induced autoimmunity despite efficient lymphocytic infiltration. Int Immunol. 1998; 10(4):405-12. DOI: 10.1093/intimm/10.4.405. View

Clevers H . At the crossroads of inflammation and cancer. Cell. 2004; 118(6):671-4. DOI: 10.1016/j.cell.2004.09.005. View

10.

McSorley S, Soldera S, Malherbe L, Carnaud C, Locksley R, Flavell R . Immunological tolerance to a pancreatic antigen as a result of local expression of TNFalpha by islet beta cells. Immunity. 1997; 7(3):401-9. DOI: 10.1016/s1074-7613(00)80361-1. View

11.

Suresh M, Singh A, Fischer C . Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection. J Virol. 2004; 79(1):202-13. PMC: 538712. DOI: 10.1128/JVI.79.1.202-213.2005. View

12.

Trevejo J, Marino M, Philpott N, Josien R, Richards E, Elkon K . TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc Natl Acad Sci U S A. 2001; 98(21):12162-7. PMC: 59785. DOI: 10.1073/pnas.211423598. View

13.

Nakae S, Asano M, Horai R, Sakaguchi N, Iwakura Y . IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J Immunol. 2001; 167(1):90-7. DOI: 10.4049/jimmunol.167.1.90. View

14.

Herrera P, Harlan D, Vassalli P . A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF. Proc Natl Acad Sci U S A. 2000; 97(1):279-84. PMC: 26654. DOI: 10.1073/pnas.97.1.279. View

15.

Greten F, Eckmann L, Greten T, Park J, Li Z, Egan L . IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004; 118(3):285-96. DOI: 10.1016/j.cell.2004.07.013. View

16.

Deng G, Zheng L, Chan F, Lenardo M . Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors. Nat Med. 2005; 11(10):1066-72. DOI: 10.1038/nm1304. View

17.

RIESER C, Bock G, Klocker H, Bartsch G, Thurnher M . Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med. 1997; 186(9):1603-8. PMC: 2199106. DOI: 10.1084/jem.186.9.1603. View

18.

Wajant H, Pfizenmaier K, Scheurich P . Tumor necrosis factor signaling. Cell Death Differ. 2003; 10(1):45-65. DOI: 10.1038/sj.cdd.4401189. View

19.

Balkwill F, Coussens L . Cancer: an inflammatory link. Nature. 2004; 431(7007):405-6. DOI: 10.1038/431405a. View

20.

CARSWELL E, Old L, Kassel R, Green S, Fiore N, Williamson B . An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975; 72(9):3666-70. PMC: 433057. DOI: 10.1073/pnas.72.9.3666. View